Supervised non-negative matrix factorization on cell-free DNA fragmentomic features enhances early cancer detection
Tran, T. H.; Pham, N. T.; Nguyen, V. T. C.; Vo, D. H.; Nguyen, T. H. H.; Tran, T. T.; Tran, T. T.; Vo, T. D. H.; Dao, T. H.; Nguyen, H. T. P.; Phan, T. V.; Ha, T. M. T.; Ngo, T. D. H.; Tran, N.-H.; Tran, N.-T.; Hoang, T. Q.; Nguyen, V. B.; Le, V. C.; Nguyen, X. C.; Nguyen, T. M. P.; Nguyen, V. H.; Tran, N. T. N.; Dang, T. N. Q.; Tran, M. H.; Nguyen, P. N.; Pham, T. A. T.; Vo, D. L.; Doan, T. N.; Nguyen, V. H.; Tran, Q. D.; Dang, Q. T.; Ho, L. M. Q.; Nguyen, V. T. A.; Nguyen, S. T.; Nguyen, H.-N.; Tran, L. S.; Giang, H.; Phan, M. D.; Nguyen, T. H.
Show abstract
BackgroundCell-free circulating DNA (cfDNA) fragments exhibit non-random patterns in their length (FLEN), end-motif (EM), and distance to nucleosome position (ND). While these cfDNA features have shown promise as inputs for machine learning and deep learning models in early cancer detection, most studies utilize them as raw inputs, overlooking the potential benefits of pre-processing to extract cancer-specific features. This study aims to enhance cancer detection accuracy by developing a novel approach to feature extraction from cfDNA fragmentomics. MethodsWe implemented a supervised non-negative matrix factorization (SNMF) algorithm to generate embedding vectors capturing cancer-specific signals within cfDNA fragmentomic features. These embeddings served as input for a machine learning model to classify cancer patients from healthy individuals. ResultsWe validated our framework using two datasets: an in-house cohort of 431 cancer patients and 442 healthy individuals (dataset 1), and a published cohort comprising 90 hepatocellular carcinoma (HCC) patients and 103 individuals with cirrhosis or hepatitis B (dataset 2). In dataset 1, we achieved an AUC of 94% in pan-cancer detection. In dataset 2, our framework achieved an AUC of 100% for HCC vs healthy classification, 99% for HCC vs non-HCC patients classification, and 96% for identifying HCC patients among a mixed group of non-HCC patients and healthy donors. ConclusionThis study demonstrates the efficiency of SNMF-transformed features in improving both pan-cancer detection and specific HCC detection. Our approach offers a significant advancement in leveraging cfDNA fragmentomics for early cancer detection, potentially enhancing diagnostic accuracy in clinical settings.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- SpatialESD: spatial ensemble domain detection in spatial transcriptomics 94%
- scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancers 94%
- Genetic deconvolution of embryonic and maternal cell-free DNA in spent culture medium of human preimplantation embryos through deep learning 94%
Similar papers in this journal
- Teacher-student collaborated multiple instance learning for pan-cancer PDL1 expression prediction from histopathology slides 96%
- MORONET: Multi-omics Integration via Graph Convolutional Networks for Biomedical Data Classification 95%
- Accurate recognition of colorectal cancer with semi-supervised deep learning on pathological images 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.